Efficacy and safety of once-daily single-inhaler triple therapy (FF/UMEC/VI) versus FF/VI in patients with inadequately controlled asthma (CAPTAIN): a double-blind, randomised, phase 3A trial - Lee, L A; Bailes, Z; Barnes, N (Lancet Respir Med, 2021)
et al.